These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 22983388)
1. Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy. Cui EH; Li HJ; Hua F; Wang B; Mao W; Feng XR; Li JY; Wang X Acta Pharmacol Sin; 2013 Feb; 34(2):309-13. PubMed ID: 22983388 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Serum miR-22, miR-125b, and miR-15b in Non-Small Cell Lung Cancer Patients. Shi GL; Zhang XY; Chen Y; Ma S; Bai WQ; Yin YJ Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538046 [TBL] [Abstract][Full Text] [Related]
3. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy. Wang F; Lou JF; Cao Y; Shi XH; Wang P; Xu J; Xie EF; Xu T; Sun RH; Rao JY; Huang PW; Pan SY; Wang H Exp Mol Med; 2015 May; 47(5):e162. PubMed ID: 25952770 [TBL] [Abstract][Full Text] [Related]
4. Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. Yuxia M; Zhennan T; Wei Z J Cancer Res Clin Oncol; 2012 Dec; 138(12):2045-50. PubMed ID: 22806310 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer. Li ZH; Zhang H; Yang ZG; Wen GQ; Cui YB; Shao GG J Int Med Res; 2013 Oct; 41(5):1437-44. PubMed ID: 24065453 [TBL] [Abstract][Full Text] [Related]
6. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer. Zhang YL; Zhang ZL; Zhu XB; Xu L; Lu P; Xu M; Liu WJ; Zhang XY; Yao HM; Ye XW Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy. Yuwen D; Ma Y; Wang D; Gao J; Li X; Xue W; Fan M; Xu Q; Shen Y; Shu Y Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):163-173. PubMed ID: 30228154 [TBL] [Abstract][Full Text] [Related]
8. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer. Shi GL; Chen Y; Sun Y; Yin YJ; Song CX Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Voortman J; Goto A; Mendiboure J; Sohn JJ; Schetter AJ; Saito M; Dunant A; Pham TC; Petrini I; Lee A; Khan MA; Hainaut P; Pignon JP; Brambilla E; Popper HH; Filipits M; Harris CC; Giaccone G Cancer Res; 2010 Nov; 70(21):8288-98. PubMed ID: 20978195 [TBL] [Abstract][Full Text] [Related]
10. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients. Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916 [TBL] [Abstract][Full Text] [Related]
12. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer. Wang SY; Li Y; Jiang YS; Li RZ Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091 [TBL] [Abstract][Full Text] [Related]
13. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer. Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer. Sun B; Liu HF; Ding Y; Li Z Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of microRNA-10b expression in peripheral blood mononuclear cells in evaluating short- and long-term efficacy of chemotherapy for patients with advanced non-small-cell lung cancer. Yang YL; Wang W; Xu LP Neoplasma; 2018; 65(4):610-619. PubMed ID: 30064233 [TBL] [Abstract][Full Text] [Related]
17. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer. Ding H; Wen W; Ding Q; Zhao X Cancer Control; 2020; 27(1):1073274820964783. PubMed ID: 33104396 [TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients. Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum miR-25 in non-small-cell lung cancer. Li J; Yu M; Liu Z; Liu B Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763 [No Abstract] [Full Text] [Related] [Next] [New Search]